Zhejiang Hisun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CYTARABINE USP, with a corresponding US DMF Number 15959.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2013, and payment made on December 18, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II